Skip to Main Content

Author Details

Melissa S Love
a Division of The Scripps Research Institute
2012
22
12
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37196868Structure-activity relationship of BMS906024 derivatives for Cryptosporidium parvum growth inhibition.Bioorg Med Chem Lett2023
34748385Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis.Antimicrob Agents Chemother2022
35703552Repurposing the Kinase Inhibitor Mavelertinib for Giardiasis Therapy.Antimicrob Agents Chemother2022
35810253Iron limitation in M. tuberculosis has broad impact on central carbon metabolism.Commun Biol2022
35149760Adaptive laboratory evolution in S. cerevisiae highlights role of transcription factors in fungal xenobiotic resistance.Commun Biol2022
35134095Pharmacological and genetic activation of cAMP synthesis disrupts cholesterol utilization in Mycobacterium tuberculosis.PLoS Pathog2022
32277809Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial.Clin Infect Dis2021
33740373Repurposing Infectious Disease Hits as Anti-<i>Cryptosporidium</i> Leads.ACS Infect Dis2021
34261904Emerging treatment options for cryptosporidiosis.Curr Opin Infect Dis2021
32892652Phenotypic screening techniques for <i>Cryptosporidium</i> drug discovery.Expert Opin Drug Discov2021
31452169High-Content Screening for Cryptosporidium Drug Discovery.Methods Mol Biol2020
32998973Bicyclic azetidines kill the diarrheal pathogen <i>Cryptosporidium</i> in mice by inhibiting parasite phenylalanyl-tRNA synthetase.Sci Transl Med2020
30894487Lysyl-tRNA synthetase as a drug target in malaria and cryptosporidiosis.Proc Natl Acad Sci U S A2019
31249291Identification of a potent benzoxaborole drug candidate for treating cryptosporidiosis.Nat Commun2019
31015448A suite of phenotypic assays to ensure pipeline diversity when prioritizing drug-like Cryptosporidium growth inhibitors.Nat Commun2019
29339392A Novel Piperazine-Based Drug Lead for Cryptosporidiosis from the Medicines for Malaria Venture Open-Access Malaria Box.Antimicrob Agents Chemother2018
30282735The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis.Proc Natl Acad Sci U S A2018
29469575Herbicidins from Streptomyces sp. CB01388 Showing Anti- Cryptosporidium Activity.J Nat Prod2018
28899690Advances in bumped kinase inhibitors for human and animal therapy for cryptosporidiosis.Int J Parasitol2017
28158186A high-throughput phenotypic screen identifies clofazimine as a potential treatment for cryptosporidiosis.PLoS Negl Trop Dis2017
23332153A host GPCR signaling network required for the cytolysis of infected cells facilitates release of apicomplexan parasites.Cell Host Microbe2013
23245326Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarials.Cell Host Microbe2012
  • 1 - 22 of 22

Recommended Authors

Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
University of California berkeley
Career Start Year 2013
Number of shared co-authors 5
CSIR - National Chemical Laboratory
Career Start Year 2008
Number of shared co-authors 2
University of Virginia School of Medicine
Career Start Year 2008
Number of shared co-authors 0
Columbia University Irving Medical Center
Career Start Year 2008
Number of shared co-authors 9
Institute of Biophysics Carlos Chagas Filho, Federal University of Rio de Janeiro
Career Start Year 2005
Number of shared co-authors 0
University of California, Davis Center for Valley Fever
Career Start Year 2005
Number of shared co-authors 0
Baruch S. Blumberg Institute
Career Start Year 2005
Number of shared co-authors 0
University of North Carolina School of Medicine
Career Start Year 2004
Number of shared co-authors 0
a division of The Scripps Research Institute La Jolla
Career Start Year 2003
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2003
Number of shared co-authors 1
University of Nebraska at Omaha
Career Start Year 2003
Number of shared co-authors 2
SAMRC/NHLS/UCT Molecular Mycobacteriology Research Unit, University of Cape Town
Career Start Year 2003
Number of shared co-authors 0
Simon Fraser University
Career Start Year 2002
Number of shared co-authors 1
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 2
Bio21 Molecular Science and Biotechnology Institute, University of Melbourne
Career Start Year 2001
Number of shared co-authors 5
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 4
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1997
Number of shared co-authors 1
National Institutes of Health Intramural Research Program
Career Start Year 1995
Number of shared co-authors 0
RWTH Aachen University
Career Start Year 1995
Number of shared co-authors 1
University of Illinois at Urbana-Champaign
Career Start Year 1995
Number of shared co-authors 1
Barcelona Institute for Global Health, Hospital Clinic, University of Barcelona
Career Start Year 1992
Number of shared co-authors 0
University of Toronto
Career Start Year 1991
Number of shared co-authors 5
Yale University School of Medicine
Career Start Year 1989
Number of shared co-authors 10
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California
Career Start Year 1987
Number of shared co-authors 8
University of Washington
Career Start Year 1986
Number of shared co-authors 3
University of Washington
Career Start Year 1984
Number of shared co-authors 2
Seattle Children's Research Institute, University of Washington
Career Start Year 1977
Number of shared co-authors 2
Harvard Medical School, Blavatnik Institute
Career Start Year 1973
Number of shared co-authors 7
Sandler Center for Drug Discovery, University of California San Francisco
Career Start Year 1970
Number of shared co-authors 15

Collaborators

a division of The Scripps Research Institute La Jolla
Co-authored papers 18
Center for Emerging and Re-emerging Infectious Diseases, University of Washington
Co-authored papers 5
University of California San Diego
Co-authored papers 2
Global Health Pharma Unit
Co-authored papers 1
SUNY Upstate Medical University
Co-authored papers 1
University of California
Co-authored papers 1
Broad Institute
Co-authored papers 1
The George Washington University School of Medicine and Health Sciences
Co-authored papers 1
University of California san francisco
Co-authored papers 1
University of California
Co-authored papers 1
Chang Gung Memorial Hospital
Co-authored papers 1
University of Toronto
Co-authored papers 1
University of Pittsburgh
Co-authored papers 1
University of Guelph
Co-authored papers 1
University of California
Co-authored papers 1
Scripps Institution of Oceanography, University of California San Diego
Co-authored papers 1
The Rockefeller University
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California
Co-authored papers 1
University of Toronto
Co-authored papers 1
Harvard T.H. Chan School of Public Health
Co-authored papers 1
The Scripps Research Institute
Co-authored papers 1
Nagoya City University
Co-authored papers 1
The Broad Institute
Co-authored papers 1
University of California
Co-authored papers 1
University of California
Co-authored papers 1
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 1
University of California San Diego
Co-authored papers 1
University of California
Co-authored papers 1
University of California
Co-authored papers 1